πŸ‡ΊπŸ‡Έ FDA
Patent

US 12215164

Immunotoxins with albumin binding domain

granted A61KA61K47/6829A61K47/6849

Quick answer

US patent 12215164 (Immunotoxins with albumin binding domain) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Feb 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K47/6829, A61K47/6849, A61K47/6889